In 2020, the Global Fund signed 157 grants for a total of US$8.54 billion for lifesaving HIV, TB and malaria programs and to strengthen systems for health. This is the highest amount of grants ever signed in a single year by the Global Fund. The grants will begin implementation this month.
The Strategic Review 2020 (SR2020) of the Global Fund and its related documents are now available. As with the SR2015 and SR2017, it was commissioned by the Technical Evaluation Reference Group (TERG).
The Global Fund has awarded nearly US$1 billion to 106 countries to support their responses to COVID-19, but has now fully deployed all its funding for this purpose. There are significant further needs for immediate funding, including for personal protective equipment (PPE), testing and treatment, and to mitigate the impact on lifesaving HIV, TB and malaria programs.
The Global Fund praises Denmark, Norway and Sweden for allocating a total US$45 million to the Global Fund’s efforts to support low- and middle-income countries to fight COVID-19. Denmark, Norway and Sweden respectively pledged DKK 25 million, NOK 285.2 million and SEK 100 million.
The Global Fund applauds the government of Canada for allocating CAD 65 million to the Global Fund’s efforts to support low- and middle-income countries to fight COVID-19, including procuring and deploying millions of COVID-19 rapid diagnostics tests as well as reinforcing health systems.
The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria has appointed Tracy Staines, a distinguished auditor and seasoned executive, as Inspector General. Staines brings over 20 years of multi-sectoral experience in audit and risk management, including eight years at the Global Fund.